Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Colostrum Market Size Laundry Care Market Size Blood Pressure Monitors Market Size Ceramic Microspheres Market SizeGlobal Disease Control and Prevention Vaccine Market Size To Exceed USD 198.60 Million by 2033
According to a research report published by Spherical Insights & Consulting, The Global Disease Control and Prevention Vaccine Market Size is Expected to Grow from USD 60.73 Million in 2023 to USD 198.60 Million by 2033, at a CAGR of 12.58% during the forecast period 2023-2033.
The disease control and prevention vaccine market is the global market dedicated to the creation, manufacture, distribution, and administration of vaccines for the prevention of infectious diseases. It encompasses vaccines for influenza, measles, polio, COVID-19, and HPV, stimulated by government immunization initiatives, research innovation, and growing public health consciousness. Furthermore, the world disease control and prevention vaccine market is propelled by growth in infectious disease incidence, mounting government immunization programs, and heightened awareness for preventive healthcare. Improvements in vaccine technology, robust R&D spending, government support, and public-private alliances also spur market growth. On top of this, emerging health threats, global travel, and pandemic preparedness drive demand for effective vaccination initiatives across the world. However, the high development costs, stringent regulatory approvals, vaccine hesitancy, storage and distribution challenges, supply chain constraints, and limited access in low-income regions are key restraints for the growth of the market.
The live-attenuated vaccines segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the product type, the global disease control and prevention vaccine market is divided into live-attenuated vaccines, inactivated vaccines, recombinant vaccines, and toxoid vaccines. Among these, the live-attenuated vaccines segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to their strong immunogenic response, long-lasting protection, and widespread use against diseases like measles, mumps, and rubella. Growth is driven by increasing vaccination programs, rising infectious disease prevalence, continuous R&D advancements, and government initiatives promoting immunization to prevent outbreaks globally.
The injectable segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the route of administration, the global disease control and prevention vaccine market is divided into oral and injectable. Among these, the injectable segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to its high efficacy, rapid immune response, and widespread use in immunization programs. Growth is driven by increasing demand for routine and travel vaccines, technological advancements in vaccine delivery, rising government initiatives, and the effectiveness of injectable vaccines in preventing severe infectious diseases.
The infectious disease segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the indication, the global disease control and prevention vaccine market is divided into infectious disease, cancer, and other indications. Among these, the infectious disease segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to the rising prevalence of viral and bacterial infections, increasing global immunization programs, and strong government support. Growth is driven by continuous vaccine development, advancements in biotechnology, pandemic preparedness, and heightened awareness of preventive healthcare to combat diseases like influenza and HPV.
North America is projected to hold the largest share of the global disease control and prevention vaccine market over the forecast period.
North America is projected to hold the largest share of the global disease control and prevention vaccine market over the forecast period. The regional growth is attributed to its advanced healthcare infrastructure, high vaccination rates, and strong government immunization programs. The presence of leading vaccine manufacturers, robust R&D investments, favorable reimbursement policies, and growing awareness about preventive healthcare further contribute to the region’s substantial market share.
Asia Pacific is expected to grow at the fastest CAGR growth of the global disease control and prevention vaccine market during the forecast period. The regional growth is attributed to rising vaccination initiatives, increasing government investments in immunization programs, and growing awareness about disease prevention. Expanding healthcare infrastructure, a large population base, rapid urbanization, and advancements in biotechnology further drive market growth. Additionally, rising outbreaks of infectious diseases boost demand for vaccines in the region.
Company Profiling
Major vendors in the global disease control and prevention vaccine market are Merck & Co., Inc., GlaxoSmithKline plc., Sanofi, AstraZeneca PLC, Pfizer Inc., Astellas Pharma Inc., Sinovac Biotech Ltd., Daiichi Sankyo, Serum Institute of India Pvt. Ltd., and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global disease control and prevention vaccine market based on the below-mentioned segments:
Global Disease Control and Prevention Vaccine Market, By Product Type
Global Disease Control and Prevention Vaccine Market, By Route of Administration
Global Disease Control and Prevention Vaccine Market, By Indication
Global Disease Control and Prevention Vaccine Market, By Regional
May 2025 - The Global Deep Fryer Market Size is Expected to Grow from USD 0.83 Billion in 2023 to USD 1.10 Billion by 2033, at a CAGR of 2.86% during the forecast period 2023-2033.
May 2025 - The Global Retail Vending Machine Market Size is Expected to Grow from USD 70.86 Billion in 2023 to USD 103.10 Billion by 2033, at a CAGR of 3.82% during the forecast period 2023-2033.
May 2025 - The Global Glass Drinkware Market Size is Expected to Grow from USD 12.40 Billion in 2023 to USD 35.95 Billion by 2033, at a CAGR of 11.23% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
